M. Vicent
Molecular Biology · 2009
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 7 citations into it
Whom M. Vicent trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Vladimir Torchilin (in Molecular Biology)
- R. Duncan (in Molecular Biology)
Papers from M. Vicent's perspective
Ordered by how strongly the researchers M. Vicent trusts endorse each paper. Same corpus, a different order for every researcher.
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy (Nature)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
- Chemistry for peptide and protein PEGylation. (Advanced Drug Delivery Reviews)
- The dawning era of polymer therapeutics (Nature reviews. Drug discovery)
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (New England Journal of Medicine)
- Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. (The Lancet)
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)